BioNTech to develop malaria vaccine
German drugmaker, BioNTech, has announced plans to develop a Messenger RNA (mRNA) - based vaccine to prevent malaria. The company, which developed the United States’ first authorised COVID-19 vaccine with an American drugmaker, Pfizer, said it...